Legacy Meridian Park Medical Center, formerly Legacy Meridian Park Hospital, is an acute care hospital in Tualatin, Oregon, United States. Opened in 1973, it is operated by Legacy Health. The facility is licensed for 150 beds, but operates only 128.

During the past decade, Legacy Meridian Park Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 60 clinical trials were completed, i.e. on average, 130.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 29 clinical trials were completed. i.e. 161.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Meridian Park Hospital" #1 sponsor was "SWOG Cancer Research Network" with 47 trials, followed by "National Cancer Institute (NCI)" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "Radiation Therapy Oncology Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Meridian Park Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Meridian Park Hospital" are "Breast Cancer" (21 trials), "Lymphoma" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Legacy Meridian Park Hospital" in a lesser frequency.

Most popular intervention types in "Legacy Meridian Park Hospital" are "Drug" (117 trials), "Other" (72 trials), "Biological" (50 trials), "Radiation" (32 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (27 trials), "Questionnaire Administration" (18 trials), "Paclitaxel" (13 trials) and "placebo" (12 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Meridian Park Hospital" are 95 trials for "All" genders, 42 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Legacy Meridian Park Hospital". undefined are not yet recruiting, 15 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Legacy Meridian Park Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Meridian Park Hospital, 3 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".